154 related articles for article (PubMed ID: 17454646)
1. Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience.
Edeline V; Bonardel G; Brisse H; Foehrenbach H; Pacquement H; Maszelin P; Gaillard JF; Michon J; Neuenschwander S
Leuk Lymphoma; 2007 Apr; 48(4):823-6. PubMed ID: 17454646
[No Abstract] [Full Text] [Related]
2. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
3. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET in malignant lymphoma: significance of positive findings.
Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
[TBL] [Abstract][Full Text] [Related]
5. The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.
Ustaalioglu BB; Seker M; Bilici A; Canpolat N; Yıldirim E; Kefeli U; Ustaalioglu R; Yilmaz BE; Salepci T; Ozdemir N; Gumus M
Med Oncol; 2011 Mar; 28(1):258-64. PubMed ID: 20155405
[TBL] [Abstract][Full Text] [Related]
6. Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
Mody RJ; Bui C; Hutchinson RJ; Frey KA; Shulkin BL
Leuk Lymphoma; 2007 Apr; 48(4):699-707. PubMed ID: 17454627
[TBL] [Abstract][Full Text] [Related]
7. Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma.
Kostakoglu L
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1413-20. PubMed ID: 18385996
[No Abstract] [Full Text] [Related]
8. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease.
Paes FM; Kalkanis DG; Sideras PA; Serafini AN
Radiographics; 2010 Jan; 30(1):269-91. PubMed ID: 20083598
[TBL] [Abstract][Full Text] [Related]
9. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
Mittal BR; Manohar K; Malhotra P; Das R; Kashyap R; Bhattacharya A; Varma N; Varma S
Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
[TBL] [Abstract][Full Text] [Related]
10. Impact of 18F-fluoro-2-deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: a prospective multicenter study.
Pommier P; Dussart S; Girinsky T; Chabaud S; Lagrange JL; Nguyen TD; Beckendorff V; D'Hombres A; Artignan X; Bondiau PY; Carrie C; Giammarile F
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):823-8. PubMed ID: 20452732
[TBL] [Abstract][Full Text] [Related]
11. PET imaging in lymphoma.
Hutchings M
Expert Rev Hematol; 2009 Jun; 2(3):261-76. PubMed ID: 21082968
[TBL] [Abstract][Full Text] [Related]
12. Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma.
Cheng G; Servaes S; Zhuang H
Leuk Lymphoma; 2013 Apr; 54(4):737-42. PubMed ID: 22957898
[TBL] [Abstract][Full Text] [Related]
13. The role of PET in lymphoma.
Jhanwar YS; Straus DJ
J Nucl Med; 2006 Aug; 47(8):1326-34. PubMed ID: 16883013
[TBL] [Abstract][Full Text] [Related]
14. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
Cheson BD
Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
[TBL] [Abstract][Full Text] [Related]
15. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
Maggialetti N; Ferrari C; Minoia C; Asabella AN; Ficco M; Loseto G; De Tullio G; de Fazio V; Calabrese A; Guarini A; Rubini G; Brunese L
Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573
[TBL] [Abstract][Full Text] [Related]
16. Primary mediastinal malignant lymphoma.
Sutcliffe SB
Semin Thorac Cardiovasc Surg; 1992 Jan; 4(1):55-67. PubMed ID: 1550890
[No Abstract] [Full Text] [Related]
17. [Semiology of the exploration of residual masses in the mediastinum using imaging techniques].
Pallardó Calatayud Y; Ferrer Puchol MD; García Conde J
Sangre (Barc); 1998 Feb; 43(1):83-6. PubMed ID: 9577187
[No Abstract] [Full Text] [Related]
18. Superior mediastinal compression: a report of five cases by malignant lymphoma.
Olumide AA; Osunkoya BO; Ngu VA
Cancer; 1971 Jan; 27(1):193-202. PubMed ID: 5107431
[No Abstract] [Full Text] [Related]
19. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
20. Large-cell lymphoma with features intermediate between Hodgkin's, primary mediastinal B-cell and grey-zone lymphoma: a conundrum on fine needle aspiration cytology.
Vitagliano G; Cretella P; Zeppa P; Caputo A
Cytopathology; 2020 Jul; 31(4):325-328. PubMed ID: 32418255
[No Abstract] [Full Text] [Related]
[Next] [New Search]
